(Total Views: 123)
Posted On: 03/21/2023 1:36:30 PM
Post# of 25485
Phase II will be another level of confidence in the Phase I results by the company and the FDA.
Nascent pledges to continue to collect and evaluate the Clinical data from the Phase I trial while readying its submission to the U.S. FDA for Phase II consideration.
$NBIO
Nascent pledges to continue to collect and evaluate the Clinical data from the Phase I trial while readying its submission to the U.S. FDA for Phase II consideration.
$NBIO
(0)
(0)
